Rapid growth in the various clinical research programs are augmenting the demand for transcriptomics technologies
Transcriptomics is rapidly developing as a scientific discipline with great market potential. The main drivers behind the fast development include the ability to produce personalized health products, the ability to deliver superior healthcare products and services, and the ability to create genetically customized viruses Pathology and therapeutic applications of transcripts in pathophysiological diseases and normal disorders are dictated by genetic and cellular factors. As such, transcriptomics technologies are required to track and isolate novel DNA elements specific to pathologies and target gene targets. Transcriptomics technologies bring together various methods of data analysis and biological data gathering to identify, monitor, and manage the transcriptional network of an organism. Among the various technologies used, RNASarser and RNA-specific Network Ab Initio (RNAS) are the two most extensively used technologies in the field of transcriptomics. RNASarser refers to RNA-gui